NF157 T16291
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
NF157 significantly decreases the expression of metalloproteinase (MMP)-3, MMP-13, which can be used in the treatment of osteoarthritis (OA). NF157 is a highly selective nanomolar P2Y11 antagonist (pKi: 7.35). The IC50s are 463 nM, 1811 ᄉM, 170 ᄉM for P2Y
CAS nr:
104869-26-3
Purity:
98%
Molecular Weight:
1437,1
SMILES:
O=C(NC1=CC(C(NC2=CC(C(NC3=CC=C(S(=O)(O[Na])=O)C4=CC(S(=O)(O[Na])=O)=CC(S(=O)(O[Na])=O)=C34)=O)=CC=C2F)=O)=CC=C1)NC5=CC(C(NC6=CC(C(NC7=CC=C(S(=O)(O[Na])=O)C8=CC(S(=O)(O[Na])=O)=CC(S(=O)(O[Na])=O)=C78)=O)=CC=C6F)=O)=CC=C5
Formula:
C49H28F2N6Na6O23S6
Pathway:
Immunology/Inflammation,Neuroscience
Target:
COX,COX
